Literature DB >> 6995480

Early bacterial clearance from murine lungs. Species-dependent phagocyte response.

S R Rehm, G N Gross, A K Pierce.   

Abstract

Two sets of phagocytic cells are available to defend the lung against inhaled bacteria. Both resident alveolar macrophages and granulocytes from the circulation have been observed in pulmonary air spaces after the deposition of bacteria; their functional roles, however, have been defined. We rendered mice selectively granulocytopenic with heterologous antiserum in order to ascertain the relative contributions of these two groups of cells in intrapulmonary bacterial killing. The clearance of Staphylococcus aureus was unimpaired in granulocytopenic animals, confirming the primary role of the alveolar macrophages in the killing of these organisms. In contrast, granulocytopenic animals cleared only 10.0+/-7.0% of an inoculum of Klebsiella pneumoniae compared with 33.0+/-4.0% clearance in normal animals (P < 0.02), and Pseudomonas aeruginosa proliferated to 513% of baseline levels in granulocytopenic animals, whereas normal mice cleared 26.8+/-10.6% of the inoculum. These findings indicate that circulating granulocytes play a major role in the clearance of the latter two organisms. This variation in cellular response to different bacterial species suggests that the defense of the lung against pathogenic bacteria is more complex than has been previously assumed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6995480      PMCID: PMC371698          DOI: 10.1172/JCI109844

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Distribution of red and white blood cells in alveolar walls.

Authors:  S Perlo; A A Jalowayski; C M Durand; J B West
Journal:  J Appl Physiol       Date:  1975-01       Impact factor: 3.531

2.  A simple chromatographic method for preparation of gamma globulin.

Authors:  H B LEVY; H A SOBER
Journal:  Proc Soc Exp Biol Med       Date:  1960-01

3.  The serum proteins in multiple myelomatosis.

Authors:  R A Kekwick
Journal:  Biochem J       Date:  1940-09       Impact factor: 3.857

4.  An apparatus for the study of airborne infection.

Authors:  D W HENDERSON
Journal:  J Hyg (Lond)       Date:  1952-03

5.  Experimental streptococcal pneumonia. I. The pathologic and bacteriologic features of the untreated disease.

Authors:  L WEINSTEIN; C G COLBURN; R SELTSER; G K MALLORY; G W WARING
Journal:  J Immunol       Date:  1951-09       Impact factor: 5.422

6.  Determinants of lung bacterial clearance in mice after acute hypoxia.

Authors:  G D Harris; W G Johanson; A K Pierce
Journal:  Am Rev Respir Dis       Date:  1977-10

7.  Intraperitoneal injection of mice.

Authors:  N A Miner; J Koehler; L Greenaway
Journal:  Appl Microbiol       Date:  1969-02

8.  Pulmonary clearance of Pseudomonas aeruginosa.

Authors:  P M Southern; B B Mays; A K Pierce; J P Sanford
Journal:  J Lab Clin Med       Date:  1970-10

9.  A method for quantitating intrapulmonary bacterial inactivation in individual animals.

Authors:  G M Green; E Goldstein
Journal:  J Lab Clin Med       Date:  1966-10

10.  Experimental pneumonia due to Pseudomonas aeruginosa in leukopenic dogs: prolongation of survival by combined treatment with passive antibody to Pseudomonas and granulocyte transfusions.

Authors:  J A Kazmierowski; H Y Reynolds; J C Kauffman; W A Durbin; R G Graw; H B Devlin
Journal:  J Infect Dis       Date:  1977-03       Impact factor: 5.226

View more
  36 in total

1.  Informative value of a mouse model of Klebsiella pneumoniae infection used as a host-resistance assay.

Authors:  J Malina; J Hofmann; J Franĕk
Journal:  Folia Microbiol (Praha)       Date:  1991       Impact factor: 2.099

Review 2.  Role of the polymorphonuclear leukocyte: interaction with nosocomial pathogens.

Authors:  G B Toews
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-01       Impact factor: 3.267

3.  Lung defenses against Pseudomonas aeruginosa in C5-deficient mice with different genetic backgrounds.

Authors:  M C Cerquetti; D O Sordelli; J A Bellanti; A M Hooke
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

4.  Antibacterial immunity of lower airways: local or localized?

Authors:  J Franĕk; J Libich; J Malina
Journal:  Folia Microbiol (Praha)       Date:  1985       Impact factor: 2.099

5.  Pseudomonas aeruginosa clearance in mice: comparison of tissue, strain, and corticosteroid effects.

Authors:  K M Nugent; C D Cox; E L Pesanti
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

6.  Interaction of primate alveolar macrophages and Legionella pneumophila.

Authors:  R F Jacobs; R M Locksley; C B Wilson; J E Haas; S J Klebanoff
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

7.  Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats.

Authors:  R Roosendaal; I A Bakker-Woudenberg; M van den Berghe-van Raffe; M F Michel
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

8.  The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia.

Authors:  Stacey L Mueller-Ortiz; Scott M Drouin; Rick A Wetsel
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

9.  Roles of tumor necrosis factor and macrophages in lipopolysaccharide-induced accumulation of neutrophils in cutaneous air pouches.

Authors:  A G Harmsen; E A Havell
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

10.  Chronic glucocorticosteroid therapy impairs staphylococcal clearance from murine lungs.

Authors:  K M Nugent; E L Pesanti
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.